Colon-targeted oral nanoliposomes loaded with psoralen alleviate DSS-induced ulcerative colitis-Reference-Cited by-同舟云学术

Colon-targeted oral nanoliposomes loaded with psoralen alleviate DSS-induced ulcerative colitis

Published:2024 Issue:12 Volume:12 Page:3212-3228
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Su Liqian¹^ORCID,Song Gaoqing¹²³,Zhou Tao¹²³,Tian Hongmei¹²³,Xin Hui¹²³,Zou Xuan²,Xu Yinghua⁴,Jin Xiaobao¹,Gui Shuiqing³,Lu Xuemei¹²^ORCID

Affiliation:

1. Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, School of BasicMedical Sciences, Guangdong Pharmaceutical University, Guangzhou 510006, People's Republic of China

2. Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, People's Republic of China

3. Intensive Care Unit, Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Shenzhen 518031, People's Republic of China

4. Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotechnology Products, National Institutes for Food and Drug Control, Beijing 102629, People's Republic of China

Abstract

Psoralen-loaded nanoliposomes have pH and microbiota-sensitive characteristics, which can target the colon after oral administration to play an anti-ulcerative colitis role.

Funder

National Natural Science Foundation of China

Sanming Project of Medicine in Shenzen Municipality

Basic and Applied Basic Research Foundation of Guangdong Province

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/BM/D4BM00321G

Reference53 articles.

1. Inflammatory Bowel Disease—Gastroenterology Diamond Jubilee Review

2. Ulcerative Colitis and Crohn’s Disease Have Similar Burden and Goals for Treatment

3. Risk of colorectal cancer in inflammatory bowel diseases

4. The Risk of Extraintestinal Cancer in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Cohort Studies